ARDS
Aridis Pharmaceuticals (ARDS)
$00
About Aridis Pharmaceuticals (ARDS)
Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.
Details
Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.10
52 Week Low
$0.00
Market cap
4,500
Dividend yield
0.00%
Volume
2,185
Avg. volume
6,298
P/E ratio
.00
Aridis Pharmaceuticals News
Details
Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.10
52 Week Low
$0.00
Market cap
4,500
Dividend yield
0.00%
Volume
2,185
Avg. volume
6,298
P/E ratio
.00